A total of 1,649 investors invested $14.8 billion in 637 digital health companies in 2020, according to the latest Mercom’s Q4 & 2020 Digital Health Funding and M&A Report.
By comparison, 1,288 investors invested $8.9 billion in 615 digital health companies in 2019.
Over 300 investors made two or more investments in 2020. To learn more about the investor data, please visit: https://mercomcapital.com/product/q4-and-annual-2020-digital-health-healthcare-it-funding-and-ma-report/
Top Digital Health Investors in 2020
General Catalyst, a venture capital firm focused on early-stage and growth investments, invested nearly $1 billion in 14 digital health companies focused on Telemedicine, Fitness, and Wellness. The investment portfolio includes Roman, CityBlock Health, Olive, Mindstrong, Tempo, Curai, and SonderMind.
Optum Ventures, a venture capital firm that invests in healthcare technology companies, invested over $500 million in 14 digital health companies. Most of the investments were made in companies focused on telehealth and mHealth apps. The investment portfolio includes – Diameter Health, Springtide, Buoy Health, Truepill, Lumeon, mPulse Mobile, and DispatchHealth.
Oak HC/FT, a venture growth equity fund that invests in digital health and financial services technology, led the investment activity. The firm has invested almost $700 million in 13 digital health companies focused on mHealth Apps, Data Analytics, Practice Management Solutions, and Telemedicine. The investment portfolio includes DispatchHealth, Sema4, Olive, Truepill, Olive, and Komodo Health.
GV (formerly Google Ventures), Alphabet’s venture capital investment arm, invested more than $800 million in 12 digital health companies focused on Data Analytics and Telemedicine. The investment portfolio includes Olive, Nym Health, Verana Health, DNAnexus, Aledade, Science 37, and Ready Responders (Ready). GV has invested nearly $2 billion in almost 50 digital health companies since 2010, according to the Mercom database.
Sequoia Capital, a venture capital firm based in California, invested nearly $600 million in 11 digital health companies focused on Data Analytics and Telemedicine. The investment portfolio includes Strava, Biofourmis, Limbix, 23andMe, Virta Health, Qure.ai, eko.ai, Olive, Miaoshou Doctor, and Maven.
Y Combinator, a venture capital firm that invests in early-stage startups, invested almost $200 million in ten digital health companies focused on Wellness, Data Analytics, Clinical Decision Support, Mobile Wireless, and mHealth Apps. The investment portfolio includes – Tempo, H1 Insights, Endpoint Health, Bodyport, and Quit Genius.
